Global Microcatheters Market is estimated to value over US$ 1.45 billion by 2033 end and register a CAGR of over 5.72% during the forecast period 2025 to 2033.
The increasing population of target-based patients who are suffering from neurovascular disorders, cardiovascular diseases and cancer, increasing number of microcatheter-assisted rising adoption of minimally invasive surgeries are some integral factors responsible for the global microcatheters market growth.
The Steerable Microcatheter Segment is expected to Proliferate Over the Forecast Period Significantly
The growing number of minimally invasive and image-guided medical procedures, a paradigm shift towards robotically operated surgical platforms, procedural advantages related to the steerable microcatheters and rising prevalence of vascular diseases are some key factors that propel the microcatheters market in the forward direction.
The liver cancer segment held the largest market share in 2018. The dominance of liver cancer segment is accredited to factors like increasing cases of liver cancer across the world and growing initiatives or research and development activities for providing liver cancer therapies using microcatheters.
Key Market Drivers in the Microcatheters Market
- Rising Prevalence of Chronic Diseases: The increasing incidence of cardiovascular, neurovascular, and oncological conditions necessitates advanced interventional tools like microcatheters. These devices enable precise delivery of therapeutic agents, enhancing treatment efficacy.
- Aging Global Population: As the global population ages, there's a corresponding rise in age-related ailments requiring minimally invasive interventions, bolstering the demand for microcatheters.
- Technological Advancements: Continuous innovations in microcatheter design, materials, and functionality have expanded their applications, improved patient outcomes, and reduced procedural risks.
- Preference for Minimally Invasive Procedures: The global shift towards less invasive medical interventions, driven by benefits like reduced recovery times and lower complication rates, has amplified the adoption of microcatheters.
Global Microcatheters Market Segmentation:
By Product Type
- Delivery Microcatheters
- Aspiration Microcatheters
- Diagnostics Microcatheters
- Steerable Microcatheters
By Product Design
- Single-Lumen Microcatheters
- Dual-Lumen Microcatheters
By Application
- Cardiovascular Applications
- Neurovascular Applications
- Peripheral Vascular Applications
- Oncological Applications
- Urological Applications
- Otolaryngological Applications
- Other Applications
By End User
- Hospitals, Surgical Centres & Speciality Clinics
- Ambulatory Care Centres
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America dominated the microcatheters market in 2022, attributed to its advanced healthcare infrastructure, high prevalence of chronic diseases, and increased adoption of minimally invasive procedures. However, the Asia Pacific region is anticipated to witness the highest CAGR during the forecast period, driven by a large patient pool, improving healthcare facilities, and rising awareness about advanced medical treatments.
Major players included in the Microcatheters Market Segmentation:
- Medtronic PLC.
- Cardinal Health, Inc
- Becton, Dickinson and Company.
- Stryker Corporation
- Boston Scientific Corporation.
- B. Braun Melsungen AG.
- Terumo Medical Corporation.
- Teleflex Incorporated.
- Asahi Intec Co., Ltd.
- Merit Medical Systems, Inc.
- Johnson & Johnson (DePuy Synthes).
- Angiodynamics.
- Cook Group
- Penumbra, Inc.
- BTG PLC.
Recent Developments by Leading Companies
Medtronic Plc: In April 2023, Medtronic received FDA clearance for its Hurricane™ PTA Balloon Catheter, designed to navigate chronic total occlusions in peripheral arteries.
Boston Scientific Corporation: In March 2024, Boston Scientific gained FDA approval for its AGENT™ Drug-Coated Balloon, the first U.S.-approved coronary drug-coated balloon to treat in-stent restenosis.
Stryker Corporation: In May 2023, Stryker acquired Cerus Endovascular, expanding its neurovascular portfolio with innovative technologies for treating intracranial aneurysms.
Teleflex Incorporated: In August 2023, Teleflex formed a partnership with a leading medical device manufacturer to develop next-generation microcatheters with enhanced functionalities.
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
- To provide with an exhaustive analysis on the global microcatheters market By Product Type, By Product Design, By Application, By End User and By Region
- To provide comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
- To evaluate and forecast micro-markets and the overall market
- To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America, Middle East & Africa
- To record, evaluate, and competitive landscape mapping- product launches, technological advancements, mergers and expansions
- Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com